ASTRAZENECA PLC
ASTRAZENECA PLC
Share · GB0009895292 · 886455 (XLON)
Overview Financial Indicators
106,68 GBP
-98,65 % -7.803,01 GBP
Closing Price XLON 06.06.2025: 10.770,00 GBX
London · Current prices and charts at MoneyPeak
06.06.2025 17:35

Current Prices from ASTRAZENECA PLC

ExchangeTickerCurrencyLast TradePriceDaily Change
XETR: XETRA
XETRA
ZEG.DE
EUR
06.06.2025 15:35
127,95 EUR
127,15 EUR
+0,63 %
XLON: London
London
AZN.L
GBX
06.06.2025 15:14
10.770,00 GBX
10.688,00 GBX
+0,77 %

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
0,00 % 1,11 % -0,82 % -11,62 % -0,54 % -15,34 % 26,15 %

Company Profile for ASTRAZENECA PLC Share

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, Byetta, Crestor, Evrenzo, Farxiga/Forxiga, Komboglyze/Kombiglyze XR, Lokelma, Onglyza, Qtern, and Xigduo/Xigduo XR for cardiovascular, renal, and metabolism diseases; Bevespi Aerosphere, Breztri Aerosphere, Daliresp/Daxas, Duaklir Genuair, Fasenra, Pulmicort, Saphnelo, Symbicort, and Tudorza/Eklira/Bretaris for respiratory and immunology; and Andexxa/Ondexxya, Kanuma, Soliris, Strensiq, and Ultomiris for rare diseases. The company's marketed products also comprise Synagis for respiratory syncytial virus; Fluenz Tetra/FluMist Quadrivalent for Influenza; Seroquel IR/Seroquel XR for schizophrenia bipolar disease; Nexium, and Losec/Prilosec for gastroenterology; and Vaxzevria and Evusheld for covid-19. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Regeneron Pharmaceuticals, Inc. to research, develop, and commercialize small molecule medicines for obesity; Neurimmune AG to develop and commercialize NI006; Ionis Pharmaceuticals, Inc. to develop eplontersen, a liver-targeted antisense therapy in Phase III development for the treatment of transthyretin amyloidosis; Proteros Biostructures GmbH to jointly discover novel small molecules for the treatment of hematological cancers; Sierra Oncology, Inc. to develop and commercialize AZD5153. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.

Invested Funds

The following funds have invested in: ASTRAZENECA PLC invested:

Fund
iShares MSCI Europe Health Care Sector UCITS ETF EUR (Acc)
Vol. in million
4.801,23
Percentage (%)
11,00 %
Fund
iShares MSCI UK UCITS ETF GBP (Acc)
Vol. in million
8.928,03
Percentage (%)
7,25 %
Fund
iShares Core FTSE 100 UCITS ETF USD Hedged (Acc)
Vol. in million
8.456,99
Percentage (%)
6,75 %
Fund
iShares Core FTSE 100 UCITS ETF GBP (Acc)
Vol. in million
116.248,56
Percentage (%)
6,75 %
Fund
iShares MSCI UK IMI ESG Leaders UCITS ETF GBP (Dist)
Vol. in million
235,17
Percentage (%)
4,34 %

Company Data

Name ASTRAZENECA PLC
Company AstraZeneca PLC
Website https://www.astrazeneca.com
Primary Exchange XLON London
WKN 886455
ISIN GB0009895292
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - General
CEO Mr. Pascal Claude Roland Soriot D.V.M., M.B.A.
Market Capitalization 184 Mrd.
Country United Kingdom
Currency GBP
Employees 94,3 T
Address 1 Francis Crick Avenue, CB2 0AA Cambridge
IPO Date 2003-12-02
Dividends from 'ASTRAZENECA PLC'
Ex-Date Dividend per Share
20.02.2025 133,07 GBX
08.08.2024 60,92 GBX
22.02.2024 123,25 GBX
10.08.2023 56,54 GBX
23.02.2023 135,30 GBX
11.08.2022 76,40 GBX
24.02.2022 108,01 GBX
12.08.2021 46,82 GBX
25.02.2021 98,00 GBX
13.08.2020 53,26 GBX

Ticker Symbols

Name Symbol
Frankfurt ZEG.F
London AZN.L
XETRA ZEG.DE

More Shares

Investors who ASTRAZENECA PLC hold also have the following shares in their portfolio:
ADOBE INC
ADOBE INC Share
ALPHABET INC - CLASS A
ALPHABET INC - CLASS A Share
AMAZON.CO INC
AMAZON.CO INC Share
APPLE INC
APPLE INC Share
BERKSHIRE HATHAWAY INC - CLASS B
BERKSHIRE HATHAWAY INC - CLASS B Share
BROADCO INC
BROADCO INC Share
CISCO SYSTEMS INC
CISCO SYSTEMS INC Share
DWS EMERGI.MARK. TYP
DWS EMERGI.MARK. TYP Fund
KRED.F.WIED.21/51 ANL
KRED.F.WIED.21/51 ANL Bond
LIBANON 16/24 MTN
LIBANON 16/24 MTN Bond
MICROSOFT CORP
MICROSOFT CORP Share
NVIDIA CORP
NVIDIA CORP Share
SISF CHINA OPPORT. A ACC.
SISF CHINA OPPORT. A ACC. Fund
TESLA INC
TESLA INC Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025